Numerous clinical trials evaluate the therapeutic efficacy, bioequivalence, and safety profile of clopidogrel across Phase 1 through Phase 4 studies for conditions including acute coronary syndrome, peripheral arterial disease, myocardial infarction, stroke, and multi-vessel coronary artery disease. Sponsored by academic medical centers, commercial entities, and research organizations, these studies represent varied recruitment statuses, including completed, actively recruiting, and not yet open protocols.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07683923 | NOT_YET_RECRUITING | SCAD; ACS (Acute Coronary Syndrome) |
Universitätsklinikum Hamburg-Eppendorf |
2027-03-01 | PHASE4 |
| NCT07572747 | NOT_YET_RECRUITING | Chronic Coronary Syndrome |
Khalid F Alhabib |
2027-04-01 | PHASE3 |
| NCT07583784 | RECRUITING | Myocardial Infarction (MI); ST-Segment Elevation Myocardial Infarction(STEMI); NSTEMI - Non-ST-Segment Elevation Myocardial Infarction; AF - Atrial Fibrillation |
Chonnam National University Hospital |
2026-08-26 | |
| NCT07744191 | NOT_YET_RECRUITING | Psoriasis (PsO); Psoriatic Arthritis (PsA) |
NYU Langone Health |
2026-09 | PHASE4 |
| NCT07384702 | NOT_YET_RECRUITING | Bacteremia Due to Staphylococcus Aureus |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2026-06 | PHASE2 |
| NCT06650488 | RECRUITING | Staphylococcus Aureus Endocarditis; Staphylococcus Aureus Septicemia; Staphylococcus Aureus Bloodstream Infection |
Todd C. Lee MD MPH FIDSA |
2026-01-15 | PHASE4 |
| NCT06763744 | NOT_YET_RECRUITING | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI); High Bleeding Risk |
Samsung Medical Center |
2025-06-01 | PHASE4 |
| NCT07237308 | NOT_YET_RECRUITING | Stroke; Ischemic; Atrial Fibrillation; Intracrnaial Arterioscelrosis; Arteriosclerosis |
Yonsei University |
2025-12 | PHASE4 |
| NCT05845489 | RECRUITING | Coronary Artery Disease |
Seoul National University Hospital |
2023-03-22 | PHASE4 |
| NCT05353140 | RECRUITING | Atrial Fibrillation; Percutaneous Coronary Intervention |
Xijing Hospital |
2022-09-01 | |
| NCT06424548 | NOT_YET_RECRUITING | Stroke; Atherosclerosis |
Ewha Womans University Seoul Hospital |
2024-05-16 | |
| NCT06901466 | RECRUITING | Mitral Regurgitation |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2025-06-13 | PHASE4 |
| NCT07180472 | NOT_YET_RECRUITING | Cerebral Small Vessel Disease |
First Affiliated Hospital of Chengdu Medical College |
2025-09-20 | PHASE4 |
| NCT05910125 | NOT_YET_RECRUITING | Ischemic Stroke |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-07 | PHASE4 |
| NCT06853535 | RECRUITING | Acute Ischemic Stroke; Clopidogrel Resistance |
Sichuan Provincial People's Hospital |
2025-05-23 | PHASE3 |
| NCT07796217 | RECRUITING | Cardiac Event; Coronary Artery Disease; Peripheral Artery Disease; Bleeding |
Seoul National University Bundang Hospital |
2023-11-15 | PHASE4 |
| NCT04014803 | RECRUITING | Coronary Artery Disease |
Samsung Medical Center |
2020-01-13 | PHASE4 |
| NCT05643651 | RECRUITING | Kawasaki Disease; Coronary Artery Aneurysm |
Children's Hospital of Fudan University |
2025-06-01 | PHASE4 |
| NCT05577988 | RECRUITING | MYOCARDIAL INFARCTION |
Assistance Publique - Hôpitaux de Paris |
2024-06-18 | PHASE3 |
| NCT06175377 | NOT_YET_RECRUITING | Chronic Total Occlusion |
Assistance Publique Hopitaux De Marseille |
2024-03-30 | |
| NCT05681702 | RECRUITING | Coronary Artery Disease |
University of Florida |
2023-02-15 | PHASE4 |
| NCT04937699 | RECRUITING | Acute Coronary Syndrome; Percutaneous Coronary Intervention |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-03-28 | PHASE4 |
| NCT06228456 | RECRUITING | Coronary Artery Disease |
University of Florida |
2024-04-01 | PHASE4 |
| NCT06577519 | RECRUITING | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) |
Jiangsu vcare pharmaceutical technology co., LTD |
2024-09-06 | PHASE3 |
| NCT04654052 | ACTIVE_NOT_RECRUITING | Acute Coronary Syndrome; Acute Myocardial Infarction; Coronary Artery Disease; Percutaneous Coronary Intervention |
Fundación EPIC |
2021-07-02 | PHASE4 |
| NCT05638867 | RECRUITING | Coronary Artery Disease; Percutaneous Coronary Intervention; Acute Coronary Syndrome |
China National Center for Cardiovascular Diseases |
2023-11-25 | PHASE4 |
| NCT07080684 | NOT_YET_RECRUITING | Chronic Coronary Syndrome |
University of Messina |
2025-12-01 | PHASE4 |
| NCT06486363 | NOT_YET_RECRUITING | Intracranial Aneurysms; Antiplatelet Drugs |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2024-08-01 | PHASE4 |
| NCT04695106 | RECRUITING | Atrial Fibrillation; Antithrombotic Therapy; Acute Coronary Syndrome; Percutaneous Coronary Interventions |
Medical University of Gdansk |
2021-10-25 | PHASE4 |
| NCT07169513 | NOT_YET_RECRUITING | Peripheral Arterial Disease; Silent Atherosclerosis |
Guy's and St Thomas' NHS Foundation Trust |
2025-10-01 | |
| NCT05926271 | RECRUITING | Acute Coronary Syndrome; CYP2C19 Polymorphism |
St. Antonius Hospital |
2023-07-15 | PHASE2 |
| NCT03378934 | RECRUITING | Coronary Artery Disease; Percutaneous Coronary Intervention |
Peking Union Medical College Hospital |
2018-09-26 | PHASE4 |
| NCT04989257 | UNKNOWN | High Ischemic Risk |
Yonsei University |
2021-08 | |
| NCT04250116 | COMPLETED | Atrial Fibrillation |
Yonsei University |
2020-04-28 | PHASE4 |
| NCT04698031 | ACTIVE_NOT_RECRUITING | Silent Brain Infarction |
VA Office of Research and Development |
2022-03-30 | PHASE4 |
| NCT06449469 | ACTIVE_NOT_RECRUITING | Aortic Valve Stenosis; Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases; Valve Disease, Aortic |
Rigshospitalet, Denmark |
2021-05-01 | |
| NCT06601127 | RECRUITING | Ischemic Stroke |
Tianjin Institute of Pharmaceutical Research Co., Ltd |
2025-02-21 | PHASE2 |
| NCT07265466 | RECRUITING | Drug Drug Interaction (DDI) |
Onconic Therapeutics Inc. |
2025-11-17 | PHASE1 |
| NCT06037889 | COMPLETED | Branch Atheromatous Disease |
Peking Union Medical College Hospital |
2023-11-09 | PHASE3 |
| NCT07597239 | ACTIVE_NOT_RECRUITING | Thrombosis; Arterial Occlusive Diseases; Thromboelastography (TEG); Peripheral Arterial Disease(PAD); Stent Thrombosis; Platelet Inhibition; PRU(Platelet Reactivity Unit) |
Massachusetts General Hospital |
2020-11-01 | |
| NCT06759272 | NOT_YET_RECRUITING | Coronary Arterial Disease (CAD); ACS (Acute Coronary Syndrome); SCAD |
Nur Hafizah Annezah binti Utuh |
2025-02 | PHASE4 |
| NCT06613191 | NOT_YET_RECRUITING | Coronary Arterial Disease (CAD); Peripheral Vascular Disease |
Ochsner Health System |
2024-10-01 | PHASE4 |
| NCT05257824 | COMPLETED | Aneurysm Cerebral; Endovascular Procedures |
Seoul National University Bundang Hospital |
2022-06-23 | PHASE4 |
| NCT06238115 | COMPLETED | Unruptured Intracranial Aneurysm; Flow Diverter; Stent-assisted Coiling; Thromboembolic Events |
Beijing Tiantan Hospital |
2024-03-04 | PHASE2; PHASE3 |
| NCT06053021 | UNKNOWN | Acute Ischemic Stroke; Thrombocytopenia |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-09-15 | |
| NCT04624854 | COMPLETED | Coronary Artery Disease; Myocardial Ischemia; Acute Coronary Syndrome; Heart Diseases; Syndrome Heart Disease; Cardiovascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Coronary Disease; Vascular Diseases |
Harbin Medical University |
2020-10-28 | PHASE4 |
| NCT06360120 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2024-04-10 | PHASE3 |
| NCT04946734 | ACTIVE_NOT_RECRUITING | PFO - Patent Foramen Ovale; Migraine |
Guangdong Provincial People's Hospital |
2021-08-12 | PHASE3 |
| NCT07067775 | COMPLETED | Acute Coronary Syndrome |
Jiangsu vcare pharmaceutical technology co., LTD |
2025-08-05 | PHASE1 |
| NCT07040787 | COMPLETED | Complement Mediated Glomerular Diseases; Hemolytic Anemia |
Chengdu Suncadia Medicine Co., Ltd. |
2025-07-08 | PHASE1 |
| NCT03568890 | ACTIVE_NOT_RECRUITING | Left Atrial Appendage Closure; Thrombosis; Stroke; TIA; Bleeding |
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec |
2018-09-01 | PHASE4 |
| NCT05278182 | UNKNOWN | Atherosclerotic Cardiovascular Disease |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2022-12 | |
| NCT05546320 | COMPLETED | Patent Foramen Ovale; Migraine |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2022-10-15 | PHASE2 |
| NCT06318481 | COMPLETED | Stent Thrombosis; Myocardial Infarction, Acute |
National Institute of Cardiovascular Diseases, Pakistan |
2024-02-19 | PHASE3 |
| NCT05718531 | UNKNOWN | Coronary Artery Ectasia |
Assiut University |
2023-02-01 | PHASE3 |
| NCT03961334 | UNKNOWN | Stroke, Ischemic |
University of Zurich |
2019-12-05 | PHASE3 |
| NCT04483583 | COMPLETED | Coronary Artery Disease |
University of Florida |
2020-12-08 | PHASE4 |
| NCT06102720 | UNKNOWN | Ischemic Stroke |
Mikhail Zykov |
2023-01-12 | PHASE4 |
| NCT05723926 | Not yet recruiting | Atrial Fibrillation|Oral Anticoagulation|Stroke|Implant |
Javelin Medical|Population Health Research Institute |
2025-01-20 | Not Applicable |
| NCT04850417 | NOT_YET_RECRUITING | Spontaneous Coronary Artery Dissection |
Spanish Society of Cardiology |
2021-04-30 | PHASE4 |
| NCT07622056 | COMPLETED | Chronic Coronary Syndrome; Coronary Artery Disease; Percutaneous Coronary Intervention |
Kaohsiung Veterans General Hospital. |
2024-01-03 | PHASE4 |
| NCT05773989 | UNKNOWN | Coronary Artery Disease; Platelet Reactivity |
St. Antonius Hospital |
2024-01-23 | PHASE4 |
| NCT05700266 | UNKNOWN | Ischemic Stroke; Intracranial Atherosclerosis; Stenosis |
The First Affiliated Hospital with Nanjing Medical University |
2023-12-30 | PHASE2; PHASE3 |
| NCT06088433 | UNKNOWN | Coronary Heart Disease |
Fu Wai Hospital, Beijing, China |
2023-11-15 | PHASE4 |
| NCT06164834 | UNKNOWN | Healthy |
HK inno.N Corporation |
2023-12-05 | PHASE1 |
| NCT04418479 | COMPLETED | Coronary Artery Disease |
Joo-Yong Hahn |
2020-08-10 | PHASE4 |
| NCT05193071 | COMPLETED | Ischemic Stroke |
General Hospital of Shenyang Military Region |
2022-07-08 | PHASE4 |
| NCT06021990 | UNKNOWN | COPD; COPD Exacerbation Acute |
Lady Reading Hospital, Pakistan |
2023-10-01 | PHASE3 |
| NCT06591312 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2022-05-01 | PHASE3 |
| NCT05671276 | UNKNOWN | Atrial Fibrillation; Left Atrial Appendage Occlusion; Silent Cerebral Embolism |
The First Affiliated Hospital with Nanjing Medical University |
2022-02-01 | PHASE4 |
| NCT04100135 | TERMINATED | Migraine; Patent Foramen Ovale; PFO - Patent Foramen Ovale |
W.L.Gore & Associates |
2021-02-05 | |
| NCT05657041 | UNKNOWN | Coronary Artery Disease; Platelet Reactivity |
St. Antonius Hospital |
2023-04-26 | PHASE2; PHASE3 |
| NCT06242145 | COMPLETED | Ischemic Stroke |
Kafrelsheikh University |
2023-01-01 | PHASE3 |
| NCT04219774 | COMPLETED | Cognition Disorder; Stroke; Occlusion Carotid |
Duke University |
2020-05-01 | PHASE2 |
| NCT05554822 | UNKNOWN | Left Atrial Appendage Occlusion; Antiplatelet Therapy |
Azienda Ospedaliero Universitaria Maggiore della Carita |
2021-06-14 | PHASE3 |
| NCT05744804 | UNKNOWN | Patient With Anterior Myocardial Infarction |
Sohag University |
2023-03-01 | |
| NCT03245489 | COMPLETED | Head and Neck Cancer |
Medical University of South Carolina |
2018-03-06 | PHASE1 |
| NCT04738097 | COMPLETED | Ischemic Stroke; Transient Ischemic Attack |
Mazandaran University of Medical Sciences |
2021-08-08 | PHASE3 |
| NCT02938182 | UNKNOWN | Migraine |
First Affiliated Hospital Xi'an Jiaotong University |
2016-10 | PHASE4 |
| NCT06120725 | COMPLETED | Ischemic Stroke |
Kafrelsheikh University |
2021-09-01 | PHASE3 |
| NCT05934799 | COMPLETED | Bioequivalence |
Pharmtechnology LLC |
2023-06-16 | PHASE1 |
| NCT05223335 | COMPLETED | Bleeding Complications |
Mayo Clinic |
2022-03-29 | PHASE4 |
| NCT04661709 | UNKNOWN | Coronary Heart Disease; Unstable Angina; Chinese Herbal Medicine |
Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
2021-03-01 | PHASE4 |
| NCT03357874 | COMPLETED | Acute Coronary Syndrome |
Assistance Publique Hopitaux De Marseille |
2018-10-28 | PHASE3 |
| NCT04688723 | UNKNOWN | Coronary Artery Disease; Myocardial Ischemia; Myocardial Infarction; Atrial Fibrillation |
Zuyderland Medisch Centrum |
2020-12-23 | PHASE4 |
| NCT04502017 | UNKNOWN | Device-Related Thrombosis; Atrial Fibrillation; Left Atrial Appendage Occlusion |
Texas Cardiac Arrhythmia Research Foundation |
2020-08-05 | PHASE4 |
| NCT05210595 | UNKNOWN | Acute Myocardial Infarction; Ticagrelor |
Dong-A University |
2022-01-01 | PHASE4 |
| NCT03161678 | COMPLETED | Myocardial Infarction; Thrombosis; Platelet Dysfunction |
University of Maryland, Baltimore |
2017-08-22 | PHASE4 |
| NCT04744571 | UNKNOWN | Coronary Artery Disease; Coronary Occlusion; Percutaneous Coronary Intervention; Chronic Total Occlusion of Coronary Artery; Drug-Eluting Stents |
Beijing Anzhen Hospital |
2021-02 | |
| NCT05162053 | COMPLETED | Acute Coronary Syndrome |
Jiangsu vcare pharmaceutical technology co., LTD |
2021-12-09 | PHASE1 |
| NCT06522113 | COMPLETED | Ischemic Stroke; TIA |
Incheon St.Mary's Hospital |
2019-07-18 | PHASE4 |
| NCT02777580 | COMPLETED | Myocardial Infarction |
KU Leuven |
2017-08-01 | PHASE4 |
| NCT06047002 | Recruiting | Peripheral Arterial Disease |
University of Leicester |
2022-09-29 | -- |
| NCT03661411 | COMPLETED | Stroke |
General Hospital of Shenyang Military Region |
2018-10-17 | PHASE4 |
| NCT03774394 | COMPLETED | Chronic Kidney Disease (CKD); Type 2 Diabetes Mellitus (T2DM); Coronary Artery Disease (CAD) |
University of Florida |
2019-08-22 | PHASE4 |
| NCT03766581 | COMPLETED | Acute Ischemic Stroke; Transient Ischemic Attack (TIA) |
Bristol-Myers Squibb |
2019-01-27 | PHASE2 |
| NCT04229264 | UNKNOWN | Critical Limb Ischemia |
Science Valley Research Institute |
2020-01-09 | PHASE3 |
| NCT05166538 | Unknown status | Multi Vessel Coronary Artery Disease |
Yonsei University |
2022-02-01 | Phase 4 |
| NCT04165538 | UNKNOWN | Hip Fracture |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2020-01 | |
| NCT05162053 | Completed | Acute Coronary Syndrome |
Jiangsu vcare pharmaceutical technology co. LTD |
2021-12-09 | Phase 1 |
| NCT03775746 | UNKNOWN | Acute Coronary Syndrome |
East and North Hertfordshire NHS Trust |
2019-01-08 | PHASE4 |
| NCT04333407 | TERMINATED | COVID-19 |
Imperial College London |
2020-04-03 | |
| NCT04168398 | COMPLETED | Ischemia; Anticoagulants |
Mansoura University |
2019-07-03 | PHASE1; PHASE2 |
| NCT04945616 | COMPLETED | Thrombosis |
Jiangsu HengRui Medicine Co., Ltd. |
2021-07-13 | PHASE1 |
| NCT04069234 | WITHDRAWN | Diabetes Mellitus; Microvascular Coronary Artery Disease |
Region Skane |
2019-09-15 | PHASE3 |
| NCT02829151 | UNKNOWN | Critical Limb Ischemia |
Yonsei University |
2017-02-21 | PHASE4 |
| NCT04809818 | COMPLETED | Acute Ischemic Stroke |
Lumosa Therapeutics Co., Ltd. |
2021-03-21 | PHASE1 |
| NCT04305587 | COMPLETED | Diabetes Mellitus Type 2 |
Pfizer |
2020-03-16 | PHASE1 |
| NCT03078465 | WITHDRAWN | Coronary Artery Disease |
Nanjing First Hospital, Nanjing Medical University |
2017-06-20 | PHASE3 |
| NCT04116931 | UNKNOWN | Acute Coronary Syndrome (ACS) |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-22 | PHASE4 |
| NCT02939872 | COMPLETED | Percutaneous Transluminal Coronary Angioplasty; Coronary Disease |
Seung-Jung Park |
2017-03-09 | PHASE4 |
| NCT02044250 | COMPLETED | Coronary Heart Disease |
Seoul National University Hospital |
2014-02 | PHASE4 |
| NCT03581409 | COMPLETED | Aneurysm, Cerebral; Endovascular Procedures |
Seoul National University Hospital |
2018-10-24 | PHASE4 |
| NCT04060914 | UNKNOWN | Antiplatelet Therapy; Coronary Artery Disease; Percutaneous Coronary Intervention |
Beijing Anzhen Hospital |
2019-08-30 | PHASE4 |
| NCT02302508 | WITHDRAWN | Diabetes |
Centre hospitalier de l'Université de Montréal (CHUM) |
2019-09-01 | PHASE4 |
| NCT02209350 | COMPLETED | Aorta-iliac Segment Lesion (C,D Type by TASC II) |
Meshalkin Research Institute of Pathology of Circulation |
2015-08-02 | PHASE1 |
| NCT01742117 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome; Stenosis |
Mayo Clinic |
2013-05 | PHASE4 |
| NCT02960126 | UNKNOWN | Atrial Fibrillation |
Chuncheon Sacred Heart Hospital |
2016-11 | PHASE3 |
| NCT04023630 | UNKNOWN | Atrial Fibrillation; Acute Coronary Syndromes |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2019-10-01 | PHASE4 |
| NCT03672097 | COMPLETED | Acute Coronary Syndrome (ACS) |
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company |
2018-10-16 | PHASE4 |
| NCT03198741 | COMPLETED | Gastrointestinal Injury; Ischemic Heart Disease |
Shenyang Northern Hospital |
2017-07-13 | PHASE4 |
| NCT03989557 | COMPLETED | Unruptured Intracranial Aneurysm; Stents; Antiplatelet Drugs |
Beijing Neurosurgical Institute |
2019-07-01 | PHASE4 |
| NCT02675205 | COMPLETED | Cerebral Aneurysm |
Fondation Ophtalmologique Adolphe de Rothschild |
2015-12 | PHASE3 |
| NCT02285751 | UNKNOWN | Critical Illness |
Medical University of Vienna |
2012-11 | PHASE2 |
| NCT02617290 | COMPLETED | Coronary Artery Disease; Myocardial Ischemia; Myocardial Infarction; Stent Thrombosis; Cardiovascular Diseases |
Assistance Publique - Hôpitaux de Paris |
2017-01-09 | PHASE3 |
| NCT04171687 | COMPLETED | Healthy |
HK inno.N Corporation |
2019-10-21 | PHASE1 |
| NCT02989558 | COMPLETED | Aortic Valve Stenosis |
University of Athens |
2016-12 | PHASE3 |
| NCT02944123 | COMPLETED | Acute Coronary Syndrome |
Dong-A University |
2016-09 | PHASE3 |
| NCT02217501 | COMPLETED | Peripheral Arterial Disease |
University of Texas Southwestern Medical Center |
2015-11 | PHASE3 |
| NCT03039205 | COMPLETED | Platelet Aggregation; Adenosine; Coronary Artery Disease; Kidney Dysfunction; Antiplatelet Therapy |
University of Sao Paulo |
2017-11-07 | PHASE2 |
| NCT02966119 | TERMINATED | Cerebral Hemorrhage |
University Hospital, Lille |
2016-12-07 | PHASE3 |
| NCT04369534 | COMPLETED | Acute Coronary Syndrome; STEMI; NSTEMI - Non-ST Segment Elevation MI; PLATELET AGGREGATION; INDIVIDUALIZED THERAPY |
University of Zagreb |
2015-12-01 | PHASE4 |
| NCT04434365 | UNKNOWN | Stable Coronary Artery Disease; Percutaneous Coronary Intervention |
Peking Union Medical College Hospital |
2019-06-21 | PHASE1; PHASE2 |
| NCT02975076 | UNKNOWN | Stroke, Acute; Ischemic Attack, Transient |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2016-12 | |
| NCT02983214 | COMPLETED | Ischemic Stroke; Peripheral Artery Disease; Diabetes Mellitus, Type 2 |
University of Ioannina |
2016-11 | PHASE4 |
| NCT02955121 | TERMINATED | Coronary Artery Disease |
Indiana University |
2016-11 | |
| NCT03062462 | UNKNOWN | Coronary Artery Disease; Clopidogrel, Poor Metabolism of |
First Affiliated Hospital of Harbin Medical University |
2017-02-10 | PHASE2; PHASE3 |
| NCT02866175 | COMPLETED | Atrial Fibrillation |
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company |
2017-02-24 | PHASE3 |
| NCT02211066 | COMPLETED | Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion) |
Hospital Clinic of Barcelona |
2014-10 | PHASE4 |
| NCT03430661 | COMPLETED | Healthy |
Viatris Innovation GmbH |
2018-01-24 | PHASE1 |
| NCT03614832 | UNKNOWN | Platelet Reactivity |
First Affiliated Hospital of Harbin Medical University |
2018-05-01 | PHASE4 |
| NCT03329261 | COMPLETED | Diabetes Mellitus, Type 2; NSTEMI - Non-ST Segment Elevation MI; Coronary Angioplasty |
Laboratoires Teriak |
2017-12-07 | PHASE4 |
| NCT03698513 | COMPLETED | Healthy Volunteers |
Bristol-Myers Squibb |
2018-10-04 | PHASE1 |
| NCT02776540 | COMPLETED | Ischemic Cerebrovascular Accident |
Ain Shams University |
2016-06-01 | PHASE4 |
| NCT02486367 | COMPLETED | Aortic Stenosis; Inflammation; Thrombosis |
University Hospitals Cleveland Medical Center |
2015-06 | PHASE4 |
| NCT03381742 | COMPLETED | Coronary Artery Disease |
First Affiliated Hospital of Harbin Medical University |
2017-12-13 | PHASE2; PHASE3 |
| NCT02548650 | COMPLETED | Myocardial Infarction; Diabetes Mellitus; Peripheral Arterial Disease |
University of Florida |
2016-03-25 | PHASE4 |
| NCT03072082 | UNKNOWN | Coronary Artery Disease(CAD) |
Jun Li |
2017-06 | PHASE4 |
| NCT02689037 | UNKNOWN | Intracranial Atherosclerosis |
The 476th Hospital of People's Liberation Army |
2016-04 | PHASE3 |
| NCT03088072 | UNKNOWN | Non-Valvular Atrial Fibrillation; Left Atrial Appendage Closure |
Scripps Health |
2017-03-23 | PHASE4 |
| NCT02556203 | TERMINATED | Transcatheter Aortic Valve Replacement |
Bayer |
2015-12-16 | PHASE3 |
| NCT02317198 | COMPLETED | Non-ST-elevation Acute Coronary Syndrome; Unstable Angina; Non-ST-elevation Myocardial Infarction |
St. Antonius Hospital |
2013-06 | PHASE4 |
| NCT01641510 | COMPLETED | Acute Coronary Syndromes |
Dong-A University |
2013-10 | PHASE3 |
| NCT03224923 | TERMINATED | Stable Coronary Syndrome; Percutaneous Coronary Intervention; Antiplatelet Therapy; Ticagrelor |
Ottawa Heart Institute Research Corporation |
2017-08-18 | PHASE4 |
| NCT02548611 | TERMINATED | Angina Pectoris |
LMU Klinikum |
2015-09 | PHASE4 |
| NCT03204695 | TERMINATED | Non-valvular Atrial Fibrillation |
Coherex Medical |
2017-05-29 | |
| NCT02327624 | COMPLETED | Coronary Artery Disease |
Sheffield Teaching Hospitals NHS Foundation Trust |
2015-06 | PHASE4 |
| NCT02817789 | TERMINATED | Aortic Valve Stenosis |
University Hospital, Bordeaux |
2016-05-09 | PHASE3 |
| NCT02505399 | COMPLETED | Atherosclerosis |
University Hospital, Toulouse |
2015-11 | PHASE4 |
| NCT03496506 | COMPLETED | Healthy Subjects |
Actelion |
2018-03-05 | PHASE1 |
| NCT02723981 | WITHDRAWN | Stable Angina; Unstable Angina; STEMI; NSTEMI; Coronary Disease |
IHF GmbH - Institut für Herzinfarktforschung |
2016-04 | PHASE4 |
| NCT05186129 | COMPLETED | Bioequivalence |
Center for Bioequivalence Studies and Clinical Research |
2018-04-06 | PHASE1 |
| NCT02428374 | UNKNOWN | Myocardial Fibrosis |
Federal University of São Paulo |
2015-05 | PHASE4 |
| NCT03392051 | COMPLETED | Elevated Lipoprotein(a); Cardiovascular Diseases |
Akcea Therapeutics |
2017-12-28 | PHASE1 |
| NCT01609842 | COMPLETED | Cardiovascular Disease; Acute Coronary Syndrome |
VA Office of Research and Development |
2014-01-20 | |
| NCT02925923 | COMPLETED | Acute Coronary Syndrome; Angina, Unstable |
University of Alabama at Birmingham |
2016-11-01 | PHASE2 |
| NCT03577652 | COMPLETED | Coronary Artery Disease; Ticagrelor |
Shenyang Northern Hospital |
2017-07-10 | |
| NCT01635426 | UNKNOWN | Recurrent Pregnancy Loss |
Ain Shams University |
2012-03 | PHASE2; PHASE3 |
| NCT04174261 | COMPLETED | Periprocedural Myocardial Infarction |
Hellenic Society of Interventional Cardiology |
2017-01-29 | PHASE4 |
| NCT03119012 | TERMINATED | Coronary Artery Disease; Stents; Atherosclerosis |
Samsung Medical Center |
2017-04-19 | PHASE4 |
| NCT02642419 | UNKNOWN | Atrial Fibrillation |
Japan Cardiovascular Research Foundation |
2015-01 | PHASE4 |
| NCT02639143 | COMPLETED | Inflammation; Thrombosis |
First Affiliated Hospital of Harbin Medical University |
2015-12 | PHASE4 |
| NCT02133989 | UNKNOWN | Carotid Stenosis |
Samsung Medical Center |
2014-06 | PHASE3 |
| NCT03006835 | UNKNOWN | Coronary Heart Disease |
Xijing Hospital |
2017-01 | PHASE4 |
| NCT02008123 | WITHDRAWN | Clopidogrel Resistance; Secondary Stroke Prevention |
Dent Neuroscience Research Center |
2013-08 | PHASE2 |
| NCT02567461 | COMPLETED | Coronary Artery Disease |
University of Florida |
2016-03 | PHASE4 |
| NCT02320357 | COMPLETED | Systemic Lupus Erythematous |
University Hospital, Bordeaux |
2015-08-19 | PHASE1; PHASE2 |
| NCT02831218 | TERMINATED | Percutaneous Transluminal Coronary Angioplasty |
Seung-Jung Park |
2016-12 | |
| NCT01661322 | TERMINATED | Stroke |
University of Nottingham |
2009-04 | PHASE3 |
| NCT03385538 | COMPLETED | Ischemic Stroke |
Zealand University Hospital |
2015-11-01 | PHASE4 |
| NCT02663713 | COMPLETED | Myocardial Infarction; Diabetes Mellitus; Renal Disease; Coronary Artery Disease |
University of Patras |
2017-01 | PHASE4 |
| NCT02224066 | COMPLETED | Severe Aortic Valve Stenosis; Transcatheter Aortic Valve Implantation; Transcatheter Aortic Valve Replacement |
Hospital de Meixoeiro |
2016-01 | PHASE4 |
| NCT03054207 | TERMINATED | Hiv |
Jules Desmeules |
2015-06 | PHASE1 |
| NCT02140801 | COMPLETED | Thrombosis |
Nanjing First Hospital, Nanjing Medical University |
2014-05-01 | PHASE4 |
| NCT01612884 | TERMINATED | Thrombosis; Coronary Artery Disease |
Indiana University |
2011-08 | PHASE4 |
| NCT02513004 | UNKNOWN | Coronary Disease |
Yongjian Wu |
2015-06 | PHASE4 |
| NCT02319941 | COMPLETED | Acute Coronary Syndrome |
Seung-Jung Park |
2015-05-20 | PHASE2 |
| NCT01777503 | COMPLETED | Acute Coronary Syndrome; Coronary Arteriosclerosis; Myocardial Ischemia; Cardiovascular Diseases |
Azienda USL Reggio Emilia - IRCCS |
2012-11 | PHASE4 |
| NCT02407314 | TERMINATED | Peripheral Arterial Disease |
Arkansas Heart Hospital |
2015-06 | PHASE4 |
| NCT01121224 | COMPLETED | Saphenous Vein Graft Atherosclerosis |
VA Office of Research and Development |
2012-01-11 | PHASE4 |
| NCT01955200 | COMPLETED | Coronary Artery Disease |
The First Affiliated Hospital with Nanjing Medical University |
2013-10-05 | PHASE4 |
| NCT01738100 | UNKNOWN | ST-Segment Elevation Myocardial Infarction |
Hyeon-Cheol Gwon |
2012-09 | PHASE2 |
| NCT02415803 | UNKNOWN | Non ST Segment Elevation Acute Coronary Syndrome |
First Affiliated Hospital of Harbin Medical University |
2014-12 | PHASE3 |
| NCT02618733 | COMPLETED | Acute Coronary Syndrome |
Dong-A University |
2014-12 | |
| NCT02457130 | UNKNOWN | Coronary Artery Disease; Diabetes Mellitus. Type 2 |
Spanish Society of Cardiology |
2015-04 | PHASE4 |
| NCT02330640 | COMPLETED | Antiplatelet Therapy of Coronary Artery Bypass |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2016-01 | PHASE4 |
| NCT02922465 | COMPLETED | Healthy |
Kowa Research Institute, Inc. |
2016-09 | PHASE1 |
| NCT02044146 | COMPLETED | Acute Coronary Syndrome; Percutaneous Coronary Intervention |
Ottawa Heart Institute Research Corporation |
2014-09 | PHASE2; PHASE3 |
| NCT00947843 | COMPLETED | Coronary Heart Disease |
Seoul National University Hospital |
2013-11 | PHASE4 |
| NCT02037412 | TERMINATED | Acute Coronary Syndrome; Acute Myocardial Infarction; Unstable Angina (Intermediate Coronary Syndrome) |
Yonsei University |
2014-01 | PHASE4 |
| NCT01732822 | COMPLETED | Peripheral Artery Disease |
AstraZeneca |
2012-12-04 | PHASE3 |
| NCT02696330 | UNKNOWN | Female , Infertility |
Ain Shams Maternity Hospital |
2015-09 | PHASE4 |
| NCT01779401 | COMPLETED | Coronary Heart Disease |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2012-09 | |
| NCT02244710 | COMPLETED | Acute Coronary Syndrome (ACS) |
Fundación Investigación Sanitaria en León |
2015-03 | |
| NCT02233790 | UNKNOWN | Myocardial Infarction; No-Reflow Phenomenon |
First Hospital of China Medical University |
2014-12 | PHASE4 |
| NCT01830543 | COMPLETED | Atrial Fibrillation; Percutaneous Coronary Intervention |
Janssen Scientific Affairs, LLC |
2013-05-10 | PHASE3 |
| NCT02411903 | UNKNOWN | Cerebral Infarction; Clopidogrel,Poor Metabolism of (Disorder) |
The Third Affiliated Hospital of Guangzhou Medical University |
2015-03 | PHASE4 |
| NCT01700322 | COMPLETED | Coronary Artery Disease |
Johannes Gutenberg University Mainz |
2012-08 | PHASE4 |
| NCT02628587 | UNKNOWN | Acute Coronary Syndrome |
Hospital Central San Luis Potosi, Mexico |
2016-02 | PHASE4 |
| NCT02224274 | COMPLETED | Cardiac Arrest; Postresuscitation Syndrome; Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction) |
University Medical Centre Ljubljana |
2014-08 | PHASE4 |
| NCT01538446 | COMPLETED | Acute Coronary Syndrome |
Assistance Publique - Hôpitaux de Paris |
2012-03 | PHASE4 |
| NCT01959451 | COMPLETED | Acute Coronary Syndrome |
LMU Klinikum |
2013-09 | PHASE4 |
| NCT02123004 | UNKNOWN | ST-Segment Elevation Myocardial Infarction |
Jinan Central Hospital |
2014-04 | PHASE4 |
| NCT02578537 | UNKNOWN | Non ST Segment Elevation Acute Coronary Syndrome; Chronic Kidney Disease |
Shenyang Northern Hospital |
2015-10 | PHASE4 |
| NCT02580149 | COMPLETED | Ischemia |
Michael Wolzt, Prof. MD |
2015-10 | PHASE4 |
| NCT02560688 | COMPLETED | Drug Interaction |
Daiichi Sankyo |
2015-12 | PHASE1 |
| NCT02121288 | WITHDRAWN | Peripheral Artery Disease; Vascular Disease; Arterial Occlusion Disease; Intermittent Claudication; Ankle Brachial Index (0.9 or Less) |
AstraZeneca |
2014-12 | PHASE4 |
| NCT02707445 | COMPLETED | Myocardial Ischemia; CLOPIDOGREL, POOR METABOLISM of (Disorder) |
Korea University Anam Hospital |
2011-09 | |
| NCT01765400 | COMPLETED | Systolic Heart Failure |
University of Nebraska |
2013-05-15 | PHASE4 |
| NCT01308671 | UNKNOWN | Coronary Artery Disease |
General Hospital of Chinese Armed Police Forces |
2010-10 | |
| NCT02071966 | TERMINATED | Non ST Segment Elevation Acute Coronary Syndrome |
Catholic University of the Sacred Heart |
2012-11 | PHASE4 |
| NCT01812330 | UNKNOWN | Acute Coronary Syndrome |
General Hospital of Chinese Armed Police Forces |
2013-01 | PHASE3 |
| NCT02459288 | UNKNOWN | Acute Coronary Syndrome; Chronic Kidney Disease; End-Stage Renal Disease |
Ping-Yen Liu |
2014-01 | PHASE4 |
| NCT01924325 | UNKNOWN | Ischemic Stroke; TIA |
Xijing Hospital |
2014-01 | PHASE2; PHASE3 |
| NCT01141153 | UNKNOWN | Atrial Fibrillation; Stroke |
Hospital Universitari Vall d'Hebron Research Institute |
2010-06 | PHASE4 |
| NCT02612480 | COMPLETED | Endotoxemia |
Radboud University Medical Center |
2015-10 | |
| NCT02502812 | COMPLETED | Cardiovascular Disease |
GlaxoSmithKline |
2015-09-04 | PHASE1 |
| NCT01994941 | COMPLETED | Acute Coronary Syndrome |
The University of Hong Kong |
2013-08 | PHASE4 |
| NCT02394145 | UNKNOWN | Chronic Kidney Disease |
Kyunghee University Medical Center |
2009-09 | PHASE3 |
| NCT01905566 | COMPLETED | Plaque, Atherosclerotic |
CHEOL WHAN LEE, M.D., Ph.D |
2013-09 | PHASE4 |
| NCT01774838 | COMPLETED | Acute Coronary Syndrome; Unstable Angina |
University of Cologne |
2014-10 | PHASE3 |
| NCT02733640 | COMPLETED | Antiplatelet Effect |
Seoul National University Bundang Hospital |
2012-10 | |
| NCT02048085 | WITHDRAWN | Acute ST Segment Elevation Myocardial Infarction; Acute Coronary Syndrome |
Medical Center of South Arkansas |
2014-01-02 | PHASE4 |
| NCT02052635 | TERMINATED | Non-ST Elevation Acute Coronary Syndrome |
AstraZeneca |
2014-09 | PHASE4 |
| NCT03587324 | COMPLETED | Vascular Surgery Patient With PAD / Carotid Stenosis |
St. Josef Hospital Bochum |
2013-02 | |
| NCT03347435 | TERMINATED | Acute Coronary Syndromes |
Azienda Ospedaliero-Universitaria di Parma |
2013-06 | |
| NCT01559298 | COMPLETED | Aortic Valve Disease; Myocardial Infarction; Stroke |
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec |
2012-03 | PHASE4 |
| NCT02054663 | COMPLETED | Acute Coronary Syndrome |
Ottawa Heart Institute Research Corporation |
2013-12 | PHASE4 |
| NCT01509365 | COMPLETED | Cardiovascular Disease; Overweight |
Les Laboratoires des Médicaments Stériles |
2011-12 | PHASE4 |
| NCT02032290 | UNKNOWN | Acute Coronary Syndrome:; Non ST Elevation Myocardial Infarction; ST Elevation Myocardial Infarction; Unstable Angina |
Azienda Policlinico Umberto I |
2014-02 | PHASE4 |
| NCT02010632 | COMPLETED | Pharmacodynamics |
Khon Kaen University |
2013-08 | PHASE1 |
| NCT02108808 | COMPLETED | Fractional Flow Reserve |
University of Patras |
2014-04 | PHASE4 |
| NCT00822536 | COMPLETED | Coronary Artery Disease; Stent Thrombosis; Myocardial Ischemia |
Assistance Publique - Hôpitaux de Paris |
2009-01 | PHASE4 |
| NCT01388660 | UNKNOWN | Coronary Artery Disease |
Ajou University School of Medicine |
2011-06 | PHASE1 |
| NCT02215993 | COMPLETED | Acute Coronary Syndrome; Platelet Function |
Federal University of São Paulo |
2013-07 | PHASE4 |
| NCT01665235 | UNKNOWN | Blood Pressure Variability; Intracranial Artery Stenosis |
RenJi Hospital |
2012-08 | |
| NCT01789814 | COMPLETED | Coronary Artery Disease |
Tufts Medical Center |
2013-07 | PHASE4 |
| NCT01743014 | UNKNOWN | Diabetes Type 2; Diabetic Nephropathy; Vascular Disease |
AHEPA University Hospital |
2012-07 | PHASE4 |
| NCT01603082 | COMPLETED | Acute Coronary Syndrome |
AstraZeneca |
2012-07 | PHASE4 |
| NCT00944333 | TERMINATED | Angina Pectoris; Silent Ischemia |
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS |
2009-07 | PHASE3 |
| NCT00977938 | COMPLETED | Coronary Artery Disease |
Baim Institute for Clinical Research |
2009-10 | PHASE4 |
| NCT01955512 | COMPLETED | Asthma |
University of Southampton |
2013-05 | PHASE2 |
| NCT01352702 | TERMINATED | Coronary Heart Disease; Atrial Fibrillation; Acute Coronary Syndrome; Atherosclerosis |
Deutsches Herzzentrum Muenchen |
2011-05 | PHASE4 |
| NCT01744288 | COMPLETED | Inhibition on Platelet Aggregation |
AstraZeneca |
2012-12 | PHASE1 |
| NCT02086903 | COMPLETED | Pharmacodynamics |
Dong-A University |
2014-02 | PHASE3 |
| NCT01069003 | COMPLETED | Coronary Artery Disease |
Medtronic Vascular |
2010-04 | PHASE4 |
| NCT02034292 | TERMINATED | Acute Coronary Syndrome |
IlDong Pharmaceutical Co Ltd |
2014-02 | PHASE1 |
| NCT02594410 | COMPLETED | Hypertension |
Lee's Pharmaceutical Limited |
2011-09 | PHASE4 |
| NCT01961856 | COMPLETED | Platelet Reactivity |
University of Patras |
2013-09 | PHASE3 |
| NCT01979445 | COMPLETED | Coronary Artery Disease (CAD) |
The Medicines Company |
2013-12-02 | PHASE2 |
| NCT01365221 | COMPLETED | Acute Coronary Syndrome |
Medstar Health Research Institute |
2010-10 | PHASE4 |
| NCT01852162 | COMPLETED | Coronary Artery Disease |
University of Florida |
2012-02 | |
| NCT02120092 | COMPLETED | Acute Coronary Syndrome |
Medical University of Vienna |
2010-10 | PHASE2 |
| NCT00776633 | UNKNOWN | Coronary Artery Disease; Atrial Fibrillation |
Deutsches Herzzentrum Muenchen |
2008-09 | PHASE4 |
| NCT02096419 | COMPLETED | Acute Coronary Syndrome |
University of Zagreb |
2012-02 | PHASE4 |
| NCT01598337 | UNKNOWN | Coronary Artery Disease |
Prince Sultan Cardiac Center, Adult Cardiology Department. |
2011-04 | PHASE3 |
| NCT00698607 | COMPLETED | Coronary Artery Disease |
Seoul National University Hospital |
2008-06 | PHASE4 |
| NCT02384070 | COMPLETED | Coronary Artery Disease |
Odessa Heart Institute |
2009-01 | |
| NCT01790997 | COMPLETED | Acute Ischemic Stroke |
Dexa Medica Group |
2012-05 | PHASE3 |
| NCT01325935 | COMPLETED | Coronary Artery Disease |
Associations for Establishment of Evidence in Interventions |
2011-04 | PHASE4 |
| NCT01523392 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2012-03 | PHASE4 |
| NCT01456546 | COMPLETED | CYP2C19 Genotypes |
University of Southern Denmark |
2011-10 | PHASE1 |
| NCT01778842 | UNKNOWN | Coronary Artery Disease |
Gennaro Sardella |
2013-03 | PHASE3 |
| NCT02060786 | COMPLETED | Acute Coronary Syndrome |
Ajou University School of Medicine |
2010-10 | PHASE4 |
| NCT01896557 | COMPLETED | Coronary Artery Disease; Drug Interaction Potentiation |
University of Sao Paulo General Hospital |
2011-10 | PHASE4 |
| NCT01960296 | COMPLETED | Clopidogrel |
Icahn School of Medicine at Mount Sinai |
2012-01 | PHASE2 |
| NCT01469416 | COMPLETED | Healthy |
University of California, San Francisco |
2012-03 | PHASE1 |
| NCT01887704 | COMPLETED | Coronary Artery Disease |
Capital Medical University |
2010-01 | |
| NCT01523366 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2012-04 | PHASE4 |
| NCT01341964 | COMPLETED | Drug Action Increased |
Population Health Research Institute |
2011-05 | PHASE4 |
| NCT01757262 | WITHDRAWN | Coronary Heart Disease |
AstraZeneca |
2013-01 | PHASE3 |
| NCT00816166 | TERMINATED | Ischemic Stroke; Transient Ischemic Attack |
Codman & Shurtleff |
2008-10 | PHASE2; PHASE3 |
| NCT01327534 | COMPLETED | Myocardial Infarction; STEMI |
Stiftung Institut fuer Herzinfarktforschung |
2011-05 | PHASE3 |
| NCT01642238 | COMPLETED | Acute Coronary Syndrome |
Juan J Badimon |
2012-07 | PHASE4 |
| NCT01159639 | COMPLETED | Coronary Artery Disease; Aspirin Resistance |
University of Zagreb |
2010-06 | PHASE4 |
| NCT01113372 | COMPLETED | Coronary Artery Disease |
Cardiovascular Research Center, Brazil |
2010-04 | PHASE4 |
| NCT01493999 | COMPLETED | Acute Coronary Syndrome |
University of Pecs |
2011-09 | PHASE4 |
| NCT01795820 | COMPLETED | Acute Coronary Syndrome |
University Magna Graecia |
2012-11 | |
| NCT01156571 | COMPLETED | Atherosclerosis; Percutaneous Coronary Intervention; Acute Coronary Syndrome |
The Medicines Company |
2010-09 | PHASE3 |
| NCT01192724 | COMPLETED | Coronary Artery Disease |
Yonsei University |
2010-03 | PHASE4 |
| NCT00749710 | UNKNOWN | Femoral Neck Fractures; Pertrochanteric Fractures; Antiaggregant Therapy |
Tel-Aviv Sourasky Medical Center |
2008-09 | |
| NCT01233167 | UNKNOWN | Coronary Artery Disease |
Sir Run Run Shaw Hospital |
2011-08 | |
| NCT01016717 | WITHDRAWN | Coronary Artery Disease |
Sheba Medical Center |
2012-12 | PHASE4 |
| NCT01138969 | COMPLETED | Peptic Ulcer |
Kaohsiung Veterans General Hospital. |
2008-08 | PHASE2 |
| NCT01186146 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2010-08 | PHASE4 |
| NCT02070159 | COMPLETED | Coronary Artery Disease |
Dong-A University |
2011-12 | PHASE3 |
| NCT01371058 | COMPLETED | Coronary Artery Disease |
Shenyang Northern Hospital |
2011-03 | PHASE4 |
| NCT01572623 | UNKNOWN | Carotid Stenosis |
Campus Bio-Medico University |
2011-07 | PHASE4 |
| NCT01269333 | COMPLETED | Drug Interaction of Clopidogrel |
Hadassah Medical Organization |
2011-01 | PHASE1 |
| NCT01135667 | COMPLETED | Coronary Artery Disease; Percutaneous Coronary Intervention; Acute Coronary Syndromes |
Lene Holmvang |
2010-09 | PHASE4 |
| NCT01505790 | COMPLETED | Acute Coronary Syndromes |
Assistance Publique Hopitaux De Marseille |
2011-07 | PHASE3 |
| NCT01094457 | COMPLETED | Acute Coronary Syndromes; Percutaneous Coronary Intervention; Clopidogrel Low Responsiveness |
Shenyang Northern Hospital |
2009-03 | PHASE4 |
| NCT01657071 | COMPLETED | Acute Coronary Syndrome |
Yuhan Corporation |
2012-03 | PHASE1 |
| NCT00059306 | COMPLETED | Cerebrovascular Accident; Hypertension |
University of British Columbia |
2003-02 | PHASE3 |
| NCT00699998 | COMPLETED | Acute Coronary Syndrome |
Eli Lilly and Company |
2008-06 | PHASE3 |
| NCT01307657 | COMPLETED | Healthy |
University of Nebraska |
2011-02-15 | |
| NCT00979589 | COMPLETED | Stroke; Transient Ischemic Attack |
Beijing Tiantan Hospital |
2009-12 | PHASE3 |
| NCT00799396 | COMPLETED | Platelet Aggregation Inhibitors; Coronary Heart Disease |
University of Maryland, Baltimore |
2006-07 | PHASE4 |
| NCT01511471 | COMPLETED | Platelet Reactivity |
University of Patras |
2012-01 | PHASE3 |
| NCT03759067 | COMPLETED | Angina, Stable |
Korea University Anam Hospital |
2010-10-18 | |
| NCT01482117 | COMPLETED | Interaction |
Inje University |
2011-11 | |
| NCT00954707 | UNKNOWN | Coronary Artery Disease |
Cordis US Corp. |
2009-08 | PHASE4 |
| NCT01465828 | COMPLETED | Acute Coronary Syndrome |
Gennaro Sardella |
2011-10 | PHASE3 |
| NCT01526122 | COMPLETED | Atherosclerosis |
Dong-A ST Co., Ltd. |
2011-09 | PHASE1 |
| NCT01335048 | COMPLETED | Stable Angina |
Ospedale Misericordia e Dolce |
2011-04 | PHASE4 |
| NCT01360437 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome |
University of Patras |
2011-05 | PHASE3 |
| NCT01267734 | UNKNOWN | Coronary Heart Disease |
Seoul National University Hospital |
2010-06 | PHASE4 |
| NCT01534117 | COMPLETED | Head Injury Trauma Blunt |
Chang, Steve S., M.D. |
2009-10 | |
| NCT01069302 | COMPLETED | Coronary Artery Disease |
Takeshi Morimoto |
2010-02 | PHASE4 |
| NCT01496261 | COMPLETED | Coronary Artery Disease |
Chong Kun Dang Pharmaceutical |
2011-08 | PHASE1 |
| NCT01260584 | COMPLETED | Coronary Artery Disease |
Daiichi Sankyo |
2010-11 | PHASE4 |
| NCT01448330 | COMPLETED | Healthy |
Hanmi Pharmaceutical Company Limited |
2011-07 | PHASE1 |
| NCT01235351 | COMPLETED | Myocardial Infarction; Percutaneous Coronary Intervention |
The TIMI Study Group |
2010-10 | PHASE2 |
| NCT01210339 | COMPLETED | Healthy Volunteers |
AstraZeneca |
2010-11 | PHASE1 |
| NCT01107925 | COMPLETED | Coronary Artery Disease |
Eli Lilly and Company |
2010-03 | PHASE1 |
| NCT01011257 | WITHDRAWN | Coronary Artery Disease |
Neil Kleiman, MD |
2009-09 | PHASE4 |
| NCT00817999 | COMPLETED | Healthy |
Creighton University |
2008-11 | PHASE4 |
| NCT00882739 | COMPLETED | Acute Myocardial Infarction |
Ospedale San Donato |
2009-04 | PHASE4 |
| NCT00950339 | COMPLETED | Coronary Heart Disease; GI Bleeding |
Tel-Aviv Sourasky Medical Center |
2009-08 | PHASE4 |
| NCT00513149 | UNKNOWN | Coronary Artery Disease |
National Taiwan University Hospital |
2006-07 | PHASE4 |
| NCT01147588 | COMPLETED | Healthy |
AstraZeneca |
2010-05 | PHASE1 |
| NCT01341600 | COMPLETED | Metabolism of Clopidogrel |
University of Maryland, Baltimore |
2010-07 | |
| NCT00862420 | COMPLETED | Peripheral Arterial Disease (PAD) |
Sanofi |
2009-02 | PHASE3 |
| NCT00827346 | COMPLETED | Platelet Reactivity |
Ottawa Heart Institute Research Corporation |
2009-01 | PHASE2; PHASE3 |
| NCT01203696 | COMPLETED | Ischemic Heart Disease |
Ruttonjee Hospital |
2010-07 | PHASE4 |
| NCT01304472 | COMPLETED | Coronary Artery Disease (CAD) |
University of Patras |
2011-02 | PHASE3 |
| NCT01263093 | COMPLETED | Major Depressive Disorder |
Eli Lilly and Company |
2010-12 | PHASE1 |
| NCT01118325 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2010-04 | PHASE2 |
| NCT00857155 | UNKNOWN | Coronary Artery Disease |
LifeBridge Health |
2009-01 | |
| NCT01663038 | COMPLETED | Coronary Artery Disease |
Chong Kun Dang Pharmaceutical |
2010-12 | PHASE1 |
| NCT00687076 | COMPLETED | Peripheral Arterial Disease |
Baylor College of Medicine |
2004-04 | PHASE4 |
| NCT01037491 | UNKNOWN | Gastric Ulcer; Duodenal Ulcer |
Taipei Veterans General Hospital, Taiwan |
2009-10 | |
| NCT01102439 | COMPLETED | Coronary Artery Disease |
Population Health Research Institute |
2010-04 | PHASE4 |
| NCT01283282 | COMPLETED | Coronary Artery Disease |
Emory University |
2008-01 | PHASE4 |
| NCT00854776 | UNKNOWN | Peptic Ulcer; Ulcer Complications |
Taipei Veterans General Hospital, Taiwan |
2009-01 | |
| NCT00611286 | COMPLETED | Coronary Artery Disease |
Marco Valgimigli |
2006-12 | PHASE4 |
| NCT00664846 | COMPLETED | Stroke |
Peking Union Medical College Hospital |
2008-04 | |
| NCT01107899 | TERMINATED | Acute Coronary Syndromes |
Eli Lilly and Company |
2009-10 | PHASE1 |
| NCT00774475 | UNKNOWN | Unstable Angina; NSTEMI |
University of Florence |
2008-11 | PHASE3 |
| NCT01062516 | COMPLETED | Acute Coronary Syndrome; Acute Myocardial Infarction |
Ruttonjee Hospital |
2010-01 | PHASE4 |
| NCT00821834 | COMPLETED | Stable Angina; Myocardial Infarction |
Sanofi |
2008-12 | PHASE3 |
| NCT00222261 | COMPLETED | Coronary Heart Disease; Angina Pectoris; Atherosclerosis |
Ullevaal University Hospital |
2003-04 | PHASE4 |
| NCT01109784 | COMPLETED | Coronary Artery Disease (CAD); Acute Coronary Syndrome (ACS) |
University of Patras |
2010-04 | PHASE3 |
| NCT00833703 | COMPLETED | Heart Defects, Congenital |
Sanofi |
2009-01 | PHASE3 |
| NCT00942175 | COMPLETED | Healthy |
Takeda |
2009-12 | PHASE1 |
| NCT00830960 | COMPLETED | Acute Coronary Syndrome |
Eli Lilly and Company |
2009-02 | PHASE3 |
| NCT01014624 | COMPLETED | Coronary Artery Disease |
Daiichi Sankyo |
2010-02 | PHASE4 |
| NCT01586975 | COMPLETED | Stroke; Myocardial Infarctions |
Northwestern University |
2007-07 | PHASE2; PHASE3 |
| NCT00751231 | COMPLETED | Percutaneous Coronary Intervention |
Portola Pharmaceuticals |
2008-12 | PHASE2 |
| NCT01212302 | COMPLETED | Coronary Artery Disease |
Ruhr University of Bochum |
2008-10 | |
| NCT00989300 | COMPLETED | Healthy |
Janssen Cilag S.A.S. |
2009-11 | PHASE1 |
| NCT00590174 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2007-10 | PHASE4 |
| NCT00484926 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2007-03 | PHASE4 |
| NCT00396877 | COMPLETED | Heart Defects, Congenital |
Sanofi |
2006-11 | PHASE3 |
| NCT00822666 | COMPLETED | Coronary Artery Disease |
Assistance Publique - Hôpitaux de Paris |
2008-10 | PHASE3 |
| NCT01112137 | COMPLETED | Blood Pressure; Endothelial Function; Platelet Function |
University of Cologne |
2005-01 | PHASE4 |
| NCT00163267 | COMPLETED | Peripheral Vascular Diseases |
University Hospital Tuebingen |
2005-09 | PHASE2; PHASE3 |
| NCT00557921 | TERMINATED | Acute Coronary Syndrome; Myocardial Infarction; Coronary Artery Disease; Percutaneous Coronary Intervention |
Cogentus Pharmaceuticals |
2007-12 | PHASE3 |
| NCT00372216 | COMPLETED | Myocardial Infarction |
Stiftung Institut fuer Herzinfarktforschung |
2006-10 | PHASE3 |
| NCT00935506 | COMPLETED | Cardiovascular Disease |
Bristol-Myers Squibb |
2009-07 | PHASE1 |
| NCT00751491 | UNKNOWN | Stable Angina; Percutaneous Coronary Intervention |
University of Roma La Sapienza |
2008-09 | PHASE3 |
| NCT00335452 | COMPLETED | Acute Coronary Disease; Angina Unstable |
Sanofi |
2006-06 | PHASE3 |
| NCT00638326 | TERMINATED | Stable Angina Pectoris; Ad Hoc Percutaneous Coronary Intervention |
University of Pecs |
2008-03 | PHASE3 |
| NCT01129414 | COMPLETED | Healthy |
Sanofi |
2009-06 | PHASE1 |
| NCT01830491 | COMPLETED | Coronary Artery Disease (CAD) |
Hanmi Pharmaceutical Company Limited |
2009-03 | PHASE4 |
| NCT01123824 | COMPLETED | Healthy |
Sanofi |
2009-04 | PHASE1 |
| NCT01012193 | COMPLETED | Coronary Artery Disease; Percutaneous Coronary Intervention |
Gyeongsang National University Hospital |
2008-01 | PHASE4 |
| NCT01032668 | COMPLETED | Coronary Artery Disease |
Bursa Postgraduate Hospital |
2008-09 | PHASE3 |
| NCT01421706 | COMPLETED | Healthy |
Inje University |
2008-07 | PHASE1 |
| NCT02171598 | COMPLETED | Healthy |
Boehringer Ingelheim |
2009-02 | PHASE1 |
| NCT00891670 | UNKNOWN | Coronary Artery Stenosis; Maximal Platelet Aggregation; Late Platelet Aggregation; High Post-Treatment Platelet Reactivity |
Gyeongsang National University Hospital |
2009-05 | PHASE3 |
| NCT00228423 | COMPLETED | Atherosclerosis |
Ottawa Heart Institute Research Corporation |
2006-05 | PHASE2 |
| NCT01129375 | COMPLETED | Healthy |
Sanofi |
2009-02 | PHASE1 |
| NCT00732290 | COMPLETED | Healthy |
Centre Hospitalier Universitaire de Saint Etienne |
2009-02 | PHASE1 |
| NCT00734123 | UNKNOWN | Atherosclerosis; Cardiovascular Diseases |
Hospital Arnau de Vilanova |
2008-04 | PHASE4 |
| NCT00249873 | COMPLETED | Atrial Fibrillation; Vascular Risk |
Sanofi |
2003-06 | PHASE3 |
| NCT00391872 | COMPLETED | Acute Coronary Syndrome |
AstraZeneca |
2006-10 | PHASE3 |
| NCT00642811 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2008-05 | PHASE2 |
| NCT00528411 | COMPLETED | Coronary Artery Disease |
AstraZeneca |
2007-10 | PHASE2 |
| NCT00775762 | UNKNOWN | Polyvascular Disease; Cardiovascular Disease |
Catholic University of the Sacred Heart |
2008-11 | PHASE3 |
| NCT00642174 | COMPLETED | Diabetes Mellitus; Coronary Artery Disease |
Eli Lilly and Company |
2008-04 | PHASE2 |
| NCT00413608 | COMPLETED | Healthy |
Assistance Publique - Hôpitaux de Paris |
2007-01 | PHASE1 |
| NCT00620646 | COMPLETED | Clopidogrel Non-Responsiveness |
Samsung Medical Center |
2008-02 | |
| NCT00386191 | COMPLETED | Cerebral Infarction |
Sanofi |
2006-09 | PHASE4 |
| NCT01621750 | COMPLETED | Fasting |
Dr. Reddy's Laboratories Limited |
2008-08 | PHASE1 |
| NCT00644657 | COMPLETED | Coronary Artery Disease; Chest Pain |
University of Oklahoma |
2007-03 | |
| NCT00566891 | COMPLETED | Coronary Artery Disease |
S. Anna Hospital |
2007-12 | PHASE4 |
| NCT00494156 | WITHDRAWN | Carotid Artery Injury; Vertebral Artery Injury |
C. Clay Cothren, MD |
2003-07 | |
| NCT01447563 | TERMINATED | Comparative Bioavailability of Clopidogrel Tablets |
Hospital Universitario Dr. Jose E. Gonzalez |
2008-05 | PHASE1 |
| NCT00330772 | COMPLETED | Coronary Artery Disease; Coronary Artery Bypass Grafting |
Hamilton Health Sciences Corporation |
2006-07 | PHASE3 |
| NCT00778193 | COMPLETED | Gastroduodenal Ulcer |
Research Associates of New York, LLP |
2007-10 | PHASE4 |
| NCT00696566 | COMPLETED | Coronary Artery Disease |
Sheffield Teaching Hospitals NHS Foundation Trust |
2007-11 | PHASE1 |
| NCT00133250 | COMPLETED | Myocardial Infarction |
Deutsches Herzzentrum Muenchen |
2003-06 | PHASE4 |
| NCT00257309 | TERMINATED | Acute Myocardial Infarction |
Spanish Society of Cardiology |
2005-04 | PHASE4 |
| NCT00262561 | COMPLETED | Intermittent Claudication |
Aalborg University Hospital |
2006-01 | PHASE4 |
| NCT01603342 | COMPLETED | Haemostasis; Healthy |
Novo Nordisk A/S |
2007-12 | PHASE1 |
| NCT00662467 | COMPLETED | Myocardial Infarction |
Hamilton Health Sciences Corporation |
2006-11 | |
| NCT00724880 | COMPLETED | Coronary Artery Disease |
Catharina Ziekenhuis Eindhoven |
2006-06 | PHASE4 |
| NCT00684203 | COMPLETED | Atherosclerosis; Myocardial Ischemia; Myocardial Infarction |
Merck Sharp & Dohme LLC |
2006-12-01 | PHASE2 |
| NCT00432120 | COMPLETED | Ischemic Heart Disease |
Charles University, Czech Republic |
2006-03 | PHASE3 |
| NCT03289520 | COMPLETED | Kidney Failure; Hemodialysis Fistula Thrombosis |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2003-01-07 | PHASE3 |
| NCT00357968 | COMPLETED | Coronary Artery Disease |
Eli Lilly and Company |
2006-08 | PHASE2 |
| NCT01512485 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2006-10 | PHASE1 |
| NCT00716924 | COMPLETED | Thrombosis |
Sanofi |
2004-05 | PHASE3 |
| NCT00243178 | TERMINATED | Atrial Fibrillation; Vascular Risk |
Sanofi |
2003-07 | PHASE3 |
| NCT00882388 | COMPLETED | Healthy |
Seoul National University Hospital |
2005-03 | PHASE4 |
| NCT00360386 | COMPLETED | Ischemia |
Sanofi |
2004-03 | PHASE2 |
| NCT00650169 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2004-12 | PHASE1 |
| NCT00714961 | COMPLETED | Acute Coronary Syndromes |
Sanofi |
2003-02 | PHASE3 |
| NCT00648947 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2004-12 | PHASE1 |
| NCT02262650 | COMPLETED | Healthy |
Boehringer Ingelheim |
2004-04 | PHASE1 |
| NCT02265289 | COMPLETED | Healthy |
Boehringer Ingelheim |
1999-01 | PHASE1 |
| NCT01630642 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00444132 | COMPLETED | Clopidogrel Non-Responsiveness |
Sheba Medical Center |
2005-03 | PHASE3 |
| NCT00238667 | COMPLETED | Cervical Artery Dissection; Carotid Artery Dissection; Vertebral Artery Dissection; Stroke |
St George's, University of London |
2005-11 | PHASE3 |
| NCT00121446 | COMPLETED | Myocardial Infarction |
University of Alberta |
2003-07 | PHASE2; PHASE3 |
| NCT00349661 | COMPLETED | Coronary Heart Disease |
University Hospital, Brest |
2006-06 | PHASE3 |
| NCT00433784 | COMPLETED | Coronary Artery Disease; Elective Percutaneous Coronary Intervention |
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal |
2004-09 | PHASE4 |
| NCT00222573 | COMPLETED | Acute Myocardial Infarction |
University of Oxford |
1999-07 | PHASE4 |
| NCT00325390 | COMPLETED | Platelet Aggregation Inhibitors; NSTEACS |
Sanofi |
2004-07 | PHASE3 |
| NCT00296803 | COMPLETED | Metabolic Syndrome x |
Sanofi |
2005-11 | PHASE4 |
| NCT00152646 | UNKNOWN | Peripheral Arterial Disease |
University Hospital, Angers |
2005-03 | PHASE4 |
| NCT00406991 | COMPLETED | Diabetes; Diabetic Retinopathy |
Schepens Eye Research Institute |
2003-06 | PHASE2 |
| NCT00020189 | COMPLETED | Head and Neck Cancer; Thromboembolism |
National Cancer Institute (NCI) |
2000-06 | PHASE2 |
| NCT00004564 | UNKNOWN | Hypercholesterolemia; Thrombosis |
National Center for Research Resources (NCRR) |
||
| NCT00050817 | COMPLETED | Arteriosclerosis |
Sanofi |
2002-10 | PHASE3 |
| NCT01630915 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00853450 | COMPLETED | Antiplatelet Effect |
AstraZeneca |
2009-02 | PHASE1 |
| NCT00109382 | COMPLETED | Transient Ischemic Attack; Stroke |
University of Calgary |
2003-05 | PHASE2; PHASE3 |
| NCT00224809 | COMPLETED | Cardiovascular Diseases; Heart Diseases; Coronary Disease |
Baylor Research Institute |
2002-09 | |
| NCT00693069 | COMPLETED | Coronary Artery Disease |
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal |
2004-09 | PHASE3 |
| NCT00174759 | COMPLETED | Arterial Occlusive Diseases |
Sanofi |
2004-09 | PHASE3 |
| NCT00140465 | COMPLETED | Coronary Disease |
Deutsches Herzzentrum Muenchen |
2004-10 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-07-06)
Check the
Clopidogrel (SR-25990C) Bisulfate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Clopidogrel (SR-25990C) Bisulfate Solubility in DMSO
- Clopidogrel (SR-25990C) Bisulfate Stock Solution
- Clopidogrel (SR-25990C) Bisulfate Storage
- Clopidogrel (SR-25990C) Bisulfate Stability
- Clopidogrel (SR-25990C) Bisulfate Molecular Weight
- Clopidogrel (SR-25990C) Bisulfate SMILES
- Clopidogrel (SR-25990C) Bisulfate CAS Number
- Clopidogrel (SR-25990C) Bisulfate Chemical Structure (2D and 3D)
- Clopidogrel (SR-25990C) Bisulfate SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.